Delivery Order SPE2DB22D1106-SPE2DB23FEPU0
Award Date 6/30/23
Potential Completion Date 7/3/23
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,509 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. The prime contractor will deliver the analgesic drug from its Conshohocken, Pennsylvania facility to support DLA requirements. No major subcontractors or set aside designations were indicated. This award draws from DLA's indefinite delivery vehicle for pharmaceuticals to supply military treatment facilities and...
- The Defense Logistics Agency awarded a $2,004.51 firm fixed price delivery order to Amerisourcebergen Drug Corp for 400 mg/200 ml vials of ropivacaine hydrochloride 0.2% injection. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements by August 25, 2023. No subcontractors or set aside designations were identified. This order is likely in support of DLA's medical supply...
- The Defense Logistics Agency awarded a $4,324.60 firm fixed price delivery order to Amerisourcebergen Drug Corp for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements. The single delivery is scheduled to take place between August 24-25, 2023. No subcontractors or set aside designations were indicated....
- The Defense Logistics Agency awarded a $1,954.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/20 ml vials of ropivacaine hydrochloride injection 1%. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order is for a single day of delivery on July 18, 2023 to fulfill DLA requirements, with no subcontractors involved. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this...
- The Defense Logistics Agency awarded a $7,619 delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. The single delivery order is for 200 ml of the specified product and will be fulfilled by August 8, 2023 out of Amerisourcebergen's facility in Conshohocken, Pennsylvania. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor for the DOD and...
- The Defense Logistics Agency awarded a $843.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/100 ml vials of ropivacaine hydrochloride injection. As the prime contractor, Amerisourcebergen will deliver 100 ml vials of the anesthetic to its facility in Conshohocken, Pennsylvania within the period of performance from August 23 to August 24, 2023. The order was placed under an existing DLA pharmaceuticals contract vehicle to support the agency's medical supply...
- The Defense Logistics Agency awarded a $2,215.18 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride, a long-acting amide local anesthetic. Performance will take place in Conshohocken, Pennsylvania under the terms of the order, which runs from June 27, 2023 through June 28, 2023. The award was made using the DLA's indefinite-delivery/indefinite-quantity federal supply schedule contracting vehicle. No subcontractors or...
- The Defense Logistics Agency awarded a $864 delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DOD and other federal agencies. Amerisourcebergen will deliver the injections from its facility in Conshohocken, Pennsylvania by August 18, 2023 under firm fixed pricing. No subcontractors or...
- The Defense Logistics Agency awarded a $3,077.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride, a long-acting local anesthetic. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 27-28, 2023. The prime contractor, Amerisourcebergen, is a pharmaceutical wholesaler and distributor that supports the medical supply needs of the Department of Defense...
- The Defense Logistics Agency awarded a $432 delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility by September 15, 2023 in accordance with firm fixed price terms. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were identified. The Defense...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB23FEPU0Delivery Order
The Defense Logistics Agency awarded a $3,664 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. The prime contractor will deliver the analgesic medication from its Conshohocken, Pennsylvania facility to support DLA requirements. No major subcontractors or set aside designations were indicated. This award draws from DLA's indefinite-delivery/indefinite-quantity pharmaceutical contracts to supply medical materials for the Department of Defense.
Generated 12/23/23, 1:19 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 6/30/23 |